S
Supernus Pharmaceuticals D
D
SUPN
42.695
USD
0.54
(1.27%)
مغلق
حجم التداول
54,257
الربح لكل سهم
1
العائد الربحي
-
P/E
37
حجم السوق
2,394,040,492
الأخبار المقالات
العنوان: Supernus Pharmaceuticals
القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.